Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Celldex Therapeutics, Inc.
About CLDX
Celldex Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on exploring the science of mast cell biology and the development of transformative therapeutics for patients. Its pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with severe inflammatory, allergic, autoimmune and other devastating diseases. Its drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases. Its Barzolvolimab (CDX-0159) is a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity, which is being studied across multiple mast cell driven diseases, including Chronic Urticarias, Prurigo Nodularis, Atopic Dermatitis and Eosinophilic Esophagitis. The Company’s bispecific platform includes CDX- 622. The CDX- 622 is a bispecific candidate for inflammatory diseases.
Find out what a historical investment in Celldex Therapeutics, Inc. would be worth today using our CLDX stock calculator.
Market Capitalisation
$2.37B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
738.86K
High today
$31.18
Low today
$30.35
Open price
$30.40
52-week high
$35.79
52-week low
$18.55
Ready to start your investing journey with Stake?
Open an accountHow do I buy CLDX shares in Australia?
Buying CLDX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Celldex Therapeutics, Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in CLDX
What is the ticker symbol of Celldex Therapeutics, Inc.?
The ticker symbol for Celldex Therapeutics, Inc. is CLDX.
How much is one share of CLDX?
One share of CLDX is valued at $30.89 as of 21 May 2026.
What is the market capitalisation of Celldex Therapeutics, Inc. CLDX?
As of 21 May 2026 Celldex Therapeutics, Inc. has a market cap of $2.37B.
What is the 52-week high for Celldex Therapeutics, Inc. stock?
The Celldex Therapeutics, Inc. 52-week high stock price is $35.79.
What is the 52-week low for Celldex Therapeutics, Inc. stock?
The Celldex Therapeutics, Inc. 52-week low stock price is $18.55.
Can I buy CLDX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy CLDX shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in CLDX on Stake
- Buy CLDX from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of CLDX from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
CLDX related stocks